The Latest Breaking News from Mindset Pharma Inc

Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family

Through its wholly-owned subsidiary, Cybin IRL Limited, Canadian-based psychedelics biotech Cybin Inc. (NYSE AMERICAN: CYBN) signed an agreement with next-gen psychedelics producer Mindset Pharma Inc.

Benzinga · Sep 27, 2022

Intranasal Psychedelics Platform Is Here, Check Out Mindset's New Development

In the process of creating optimized next-generation psychedelic medicines for neurological and psychiatric disorders, drug discovery and development company Mindset Pharma Inc.

Benzinga · Jun 30, 2022

Mindset Partners With Canadian Psychiatric Research Hospital For Preclinical Study Of Psilocybin-Derived MSP-1014

Mindset Pharma Inc.

Benzinga · Jun 22, 2022